Literature DB >> 7729468

Invasive streptococci.

R C Spencer1.   

Abstract

Before the introduction of antibiotics, serious infections caused by Streptococcus pyogenes (Lancefield Group A streptococci) were common. Before World War II, this bacterium was responsible for as many as 50% of postpartum deaths and was the major cause of death in patients with burns. Also common were the sequelae of streptococcal infections-rheumatic fever and post-streptococcal glomerulonephritis. With the use of penicillin, however, Streptococcus pyogenes was believed to be virtually eliminated as a pathogen. The organism was consigned to the history books, but not for long. In the mid-1980s, focal resurgences of rheumatic fever began to be reported from different areas in the USA, such as Salt Lake City, Utah. In such communities, where increases in cases of rheumatic fever had been reported, the serotypes M-1, 3, 5, 6 and 18 were isolated which, on culture, produced characteristic mucoid colonies. At the same time, reports of increases in invasive streptococcal disease began to surface in both the USA and Europe. Two syndromes were described; invasive streptococcal infection, occurring in previously healthy children and adults, commonly associated with septicaemia resulting from a deep focus of infection such as bone or lung; and streptococcal toxic shock syndrome, involving a cutaneous focus, accompanied by necrotizing or bullous soft tissue changes. Septicaemia is rare in streptococcal toxic shock syndrome, but the most characteristic feature is one of rapidly progressing multi-organ failure. A high proportion of the strains of Streptococcus pyogenes associated with this condition are serotype M-1, and fatality rates approaching 50% have been reported.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729468

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  6 in total

1.  Inhibition of group A streptococcus infection by carboxyfullerene.

Authors:  N Tsao; T Y Luh; C K Chou; J J Wu; Y S Lin; H Y Lei
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Streptococcal pyrogenic exotoxin B induces apoptosis and reduces phagocytic activity in U937 cells.

Authors:  C F Kuo; J J Wu; P J Tsai; F J Kao; H Y Lei; M T Lin; Y S Lin
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Synergistic effects of streptolysin S and streptococcal pyrogenic exotoxin B on the mouse model of group A streptococcal infection.

Authors:  Chih-Hsin Hung; Nina Tsao; Yi-Fang Zeng; Shiou-Ling Lu; Chiang-Ni Chuan; Yee-Shin Lin; Jiunn-Jong Wu; Chih-Feng Kuo
Journal:  Med Microbiol Immunol       Date:  2012-05-18       Impact factor: 3.402

4.  Group A streptococcal genotypes from throat and skin isolates in the United Arab Emirates.

Authors:  Mubarak S Alfaresi
Journal:  BMC Res Notes       Date:  2010-04-06

5.  Epidemiology and molecular characterization of Streptococcus pyogenes recovered from scarlet fever patients in central Taiwan from 1996 to 1999.

Authors:  Chien-Shun Chiou; Tsai-Ling Liao; Tzu-Hui Wang; Hsiu-Li Chang; Jui-Cheng Liao; Chun-Chin Li
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

6.  Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection.

Authors:  C F Kuo; J J Wu; K Y Lin; P J Tsai; S C Lee; Y T Jin; H Y Lei; Y S Lin
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.